Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial. (otvara se novi prozor)

Abdel-Aleem H, Alhusaini TK, Abdel-Aleem MA, Menoufy M, Gülmezoglu AM.

Izvor‎: J Matern Fetal Neonatal Med 2013;26(17):1705-9.

Indeks‎: PubMed 23574458

https://www.ncbi.nlm.nih.gov/pubmed/23574458 (otvara se novi prozor)

Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. (otvara se novi prozor)

Gayet-Ageron A, Prieto-Merino D, Ker K, Shakur H, Ageron FX, Roberts I; Antifibrinolytic Trials Collaboration

Izvor‎: Lancet 2018;391(10116):125-32.

Indeks‎: PubMed 29126600

DOI‎: 10.1016/S0140-6736(17)32455-8

https://www.ncbi.nlm.nih.gov/pubmed/29126600 (otvara se novi prozor)

Can intravenous injection of tranexamic acid be used in routine practice with active management of the third stage of labor in vaginal delivery? A randomized controlled study. (otvara se novi prozor)

Gungorduk K, Asıcıoğlu O, Yıldırım G, Ark C, Tekirdağ Aİ, Besımoglu B.

Izvor‎: Am J Perinatol 2013;30(5):407-13.

Indeks‎: PubMed 23023559

DOI‎: 10.1055/s-0032-1326986

https://www.ncbi.nlm.nih.gov/pubmed/23023559 (otvara se novi prozor)

Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study. (otvara se novi prozor)

Gungorduk K, Yıldırım G, Asıcıoğlu O, Gungorduk OC, Sudolmus S, Ark C.

Izvor‎: Am J Perinatol 2011;28(3):233-40.

Indeks‎: PubMed 20979013

https://www.ncbi.nlm.nih.gov/pubmed/20979013 (otvara se novi prozor)

Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. (otvara se novi prozor)

Shakur S, Roberts I, Fawole B, Chaudhri R, El-Sheikh M, et al.; WOMAN Trial Collaborators

Izvor‎: Lancet 2017;389(10084):2105-16.

Indeks‎: PubMed 28456509

DOI‎: 10.1016/S0140-6736(17)30638-4

https://www.ncbi.nlm.nih.gov/pubmed/28456509 (otvara se novi prozor)

Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials. (otvara se novi prozor)

Simonazzi G, Bisulli M, Saccone G, Moro E, Marshall A, Berghella V.

Izvor‎: Acta Obstet Gynecol Scand 2016;95(1):28-37.

Indeks‎: PubMed 26698831

DOI‎: 10.1111/aogs.12798

https://www.ncbi.nlm.nih.gov/pubmed/26698831 (otvara se novi prozor)

Randomized controlled trial of tranexamic acid among parturients at increased risk for postpartum hemorrhage undergoing cesarean delivery. (otvara se novi prozor)

Sujata N, Tobin R, Kaur R, Aneja A, Khanna M, Hanjoora VM.

Izvor‎: Int J Gynaecol Obstet 2016;133(3):312-5.

Indeks‎: PubMed 26952346

DOI‎: 10.1016/j.ijgo.2015.09.032

https://www.ncbi.nlm.nih.gov/pubmed/26952346 (otvara se novi prozor)

Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004. (otvara se novi prozor)

Alfirevic Z, Elbourne D, Pavord S, Bolte A, Van Geijn H, Mercier F, Ahonen J, Bremme K, Bødker B, Magnúsdóttir EM, Salvesen K, Prendiville W, Truesdale A, Clemens F, Piercy D, Gyte G.

Izvor‎: Obstet Gynecol 2007;110(6):1270-8.

Indeks‎: PubMed 18055720

DOI‎: 10.1097/01.AOG.0000288515.48066.99

https://www.ncbi.nlm.nih.gov/pubmed/18055720 (otvara se novi prozor)

The use of recombinant activated FVII in postpartum hemorrhage. (otvara se novi prozor)

Franchini M, Franchi M, Bergamini V, Montagnana M, Salvagno GL, Targher G, Lippi G.

Izvor‎: Clin Obstet Gynecol 2010;53(1):219-27.

Indeks‎: PubMed 20142658

DOI‎: 10.1097/GRF.0b013e3181cc4378

https://www.ncbi.nlm.nih.gov/pubmed/20142658 (otvara se novi prozor)

Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study. (otvara se novi prozor)

Huber AW, Raio L, Alberio L, Ghezzi F, Surbek DV.

Izvor‎: J Perinat Med 2011;40(1):43-9.

Indeks‎: PubMed 22017328

DOI‎: 10.1515/JPM.2011.109

https://www.ncbi.nlm.nih.gov/pubmed/22017328 (otvara se novi prozor)

Postpartum hemorrhage: when uterotonics and sutures fail. (otvara se novi prozor)

James AH, McLintock C, Lockhart E.

Izvor‎: Am J Hematol 2012;87 Suppl 1:S16-22.

Indeks‎: PubMed 22430921

DOI‎: 10.1002/ajh.23156

https://www.ncbi.nlm.nih.gov/pubmed/22430921 (otvara se novi prozor)

Recombinant activated factor VII (rFVIIa/NovoSeven®) in the management of severe postpartum haemorrhage: initial report of a multicentre case series in Japan. (otvara se novi prozor)

Kobayashi T, Nakabayashi M, Yoshioka A, Maeda M, Ikenoue T.

Izvor‎: Int J Hematol 2012;95(1):57-63.

Indeks‎: PubMed 22160834

DOI‎: 10.1007/s12185-011-0974-9

https://www.ncbi.nlm.nih.gov/pubmed/22160834 (otvara se novi prozor)

Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial. (otvara se novi prozor)

Lavigne-Lissalde G, Aya AG, Mercier FJ, Roger-Christoph S, Chauleur C, Morau E, Ducloy-Bouthors AS, Mignon A, Raucoules M, Bongain A, Boehlen F, de Moerloose P, Bouvet S, Fabbro-Peray P, Gris JC.

Izvor‎: J Thromb Haemost 2015;13(4):520-9.

Indeks‎: PubMed 25594352

DOI‎: 10.1111/jth.12844

https://www.ncbi.nlm.nih.gov/pubmed/25594352 (otvara se novi prozor)

Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy. (otvara se novi prozor)

Lim Y, Loo CC, Chia V, Fun W.

Izvor‎: Int J Gynaecol Obstet 2004;87(2):178-9.

Indeks‎: PubMed 15491576

DOI‎: 10.1016/j.ijgo.2004.08.007

https://www.ncbi.nlm.nih.gov/pubmed/15491576 (otvara se novi prozor)

Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. (otvara se novi prozor)

Moscardó F, Pérez F, de la Rubia J, Balerdi B, Lorenzo JI, Senent ML, Aznar I, Carceller S, Sanz MA.

Izvor‎: Br J Haematol 2001;114(1):174-6.

Indeks‎: PubMed 11472364

https://www.ncbi.nlm.nih.gov/pubmed/11472364 (otvara se novi prozor)

Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage. (otvara se novi prozor)

Nohira T, Osakabe Y, Suda S, Takahashi C, Tanaka A, Ikeda K, Ikeda T, Okabe K.

Izvor‎: J Obstet Gynaecol Res 2008;34(4 Pt 2):623-30.

Indeks‎: PubMed 18840167

https://www.ncbi.nlm.nih.gov/pubmed/18840167 (otvara se novi prozor)

Recombinant factor VIIa as last-resort treatment of desperate haemorrhage. (otvara se novi prozor)

Palmason R, Vidarsson B, Sigvaldason K, Ingimarsson JP, Gudbjartsson T, Sigurdsson GH, Onundarson PT.

Izvor‎: Acta Anaesthesiol Scand 2012;56(5):636-44.

Indeks‎: PubMed 22489992

DOI‎: 10.1111/j.1399-6576.2012.02688.x

https://www.ncbi.nlm.nih.gov/pubmed/22489992 (otvara se novi prozor)

Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation. (otvara se novi prozor)

Pepas LP, Arif-Adib M, Kadir RA.

Izvor‎: Obstet Gynecol 2006;108(3 Pt 2):757-61.

Indeks‎: PubMed 17018493

DOI‎: 10.1097/01.AOG.0000197064.44340.d4

https://www.ncbi.nlm.nih.gov/pubmed/17018493 (otvara se novi prozor)

Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. (otvara se novi prozor)

Phillips LE, McLintock C, Pollock W, Gatt S, Popham P, Jankelowitz G, Ogle R, Cameron PA; Australian and New Zealand Haemostasis Registry.

Izvor‎: Anesth Analg 2009;109(6):1908-15.

Indeks‎: PubMed 19923520

DOI‎: 10.1213/ANE.0b013e3181c039e6

https://www.ncbi.nlm.nih.gov/pubmed/19923520 (otvara se novi prozor)

Recombinant factor VIIa to successfully manage disseminated intravascular coagulation from amniotic fluid embolism. (otvara se novi prozor)

Prosper SC, Goudge CS, Lupo VR.

Izvor‎: Obstet Gynecol 2007;109(2 Pt2):524-5.

Indeks‎: PubMed 17267882

DOI‎: 10.1097/01.AOG.0000235711.11817.8c

https://www.ncbi.nlm.nih.gov/pubmed/17267882 (otvara se novi prozor)

The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage--an observational study. (otvara se novi prozor)

Ahmed S, Harrity C, Johnson S, Varadkar S, McMorrow S, Fanning R, Flynn CM, O'Riordan JM, Byrne BM.

Izvor‎: Transfus Med 2012;22(5):344-9.

Indeks‎: PubMed 22994449

https://www.ncbi.nlm.nih.gov/pubmed/22994449 (otvara se novi prozor)

The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. (otvara se novi prozor)

Bell SF, Rayment R, Collins PW, Collis RE.

Izvor‎: Int J Obstet Anesth 2010;19(2):218-23.

Indeks‎: PubMed 20194010

DOI‎: 10.1016/j.ijoa.2009.08.004

https://www.ncbi.nlm.nih.gov/pubmed/20194010 (otvara se novi prozor)

Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. (otvara se novi prozor)

Cortet M, Deneux-Tharaux C, Dupont C, Colin C, Rudigoz RC, Bouvier-Colle MH, Huissoud C.

Izvor‎: Br J Anaesth 2012;108(6):984-9.

Indeks‎: PubMed 22490316

DOI‎: 10.1093/bja/aes096

https://www.ncbi.nlm.nih.gov/pubmed/22490316 (otvara se novi prozor)

Association between fibrinogen levels and severity of postpartum hemorrhage in singleton vaginal deliveries at a Japanese perinatal center. (otvara se novi prozor)

Shibata Y, Shigemi D, Ito M, Terada K, Nakanishi K, Kato M, Igarashi M, Suzuki S.

Izvor‎: J Nippon Med Sch 2014;81(2):94-6.

Indeks‎: PubMed 24805095

https://www.ncbi.nlm.nih.gov/pubmed/24805095 (otvara se novi prozor)

A systematic review: the use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy. (otvara se novi prozor)

Trigg DE, Stergiotou I, Peitsidis P, Kadir RA.

Izvor‎: Haemophilia 2012;18(1):25-33.

Indeks‎: PubMed 21624012

DOI‎: 10.1111/j.1365-2516.2011.02573.x

https://www.ncbi.nlm.nih.gov/pubmed/21624012 (otvara se novi prozor)

Tisseel for management of traumatic postpartum haemorrhage. (otvara se novi prozor)

Dhulkotia JS, Alazzam M, Galimberti A.

Izvor‎: Arch Gynecol Obstet 2009;279(3):437-9.

Indeks‎: PubMed 18985368

DOI‎: 10.1007/s00404-008-0824-z

https://www.ncbi.nlm.nih.gov/pubmed/18985368 (otvara se novi prozor)

Use of FloSeal haemostatic gel in massive obstetric haemorrhage: a case report. (otvara se novi prozor)

Moriarty KT, Premila S, Bulmer PJ.

Izvor‎: BJOG 2008;115(6):793-5.

Indeks‎: PubMed 18355369

DOI‎: 10.1111/j.1471-0528.2007.01654.x

https://www.ncbi.nlm.nih.gov/pubmed/18355369 (otvara se novi prozor)

Topical application of recombinant activated factor VII during cesarean delivery for placenta previa. (otvara se novi prozor)

Schjoldager BTBG, Mikkelsen E, Lykke MR, Præst J, Hvas AM, Heslet L, Secher NJ, Salvig JD, Uldbjerg N

Izvor‎: Am J Obstet Gynecol 2017;216(6):608.e1-5.

Indeks‎: PubMed 28219621

DOI‎: 10.1016/j.ajog.2017.02.024

https://www.ncbi.nlm.nih.gov/pubmed/28219621 (otvara se novi prozor)

Fibrin sealant for management of complicated obstetric lacerations. (otvara se novi prozor)

Whiteside JL, Asif RB, Novello RJ.

Izvor‎: Obstet Gynecol 2010;115(2 Pt 2):403-4.

Indeks‎: PubMed 20093858

DOI‎: 10.1097/AOG.0b013e3181bb1e28

https://www.ncbi.nlm.nih.gov/pubmed/20093858 (otvara se novi prozor)

Role of thromboelastography versus coagulation screen as a safety predictor in pre-eclampsia/eclampsia patients undergoing lower-segment caesarean section in regional anaesthesia. (otvara se novi prozor)

Ahmad A, Kohli M, Malik A, Kohli M, Bogra J, Abbas H, Gupta R, Kushwaha BB.

Izvor‎: J Obstet Gynaecol India 2016;66(Suppl 1):340-6.

Indeks‎: PubMed 27651627

https://www.ncbi.nlm.nih.gov/pubmed/27651627 (otvara se novi prozor)

Assessment of coagulation in the obstetric population using ROTEM® thromboelastometry. (otvara se novi prozor)

Armstrong S, Fernando R, Ashpole K, Simons R, Columb M.

Izvor‎: Int J Obstet Anesth 2011;20(4):293-8.

Indeks‎: PubMed 21835606

https://www.ncbi.nlm.nih.gov/pubmed/21835606 (otvara se novi prozor)

Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. (otvara se novi prozor)

de Lange NM, Lancé MD, de Groot R, Beckers EA, Henskens YM, Scheepers HC.

Izvor‎: Obstet Gynecol Surv 2012;67(7):426-35.

Indeks‎: PubMed 22926249

DOI‎: 10.1097/OGX.0b013e3182605861

https://www.ncbi.nlm.nih.gov/pubmed/22926249 (otvara se novi prozor)

Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both? (otvara se novi prozor)

Karlsson O, Jeppsson A, Hellgren M.

Izvor‎: Int J Obstet Anesth 2014;23(1):10-7.

Indeks‎: PubMed 24342222

https://www.ncbi.nlm.nih.gov/pubmed/24342222 (otvara se novi prozor)

Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. (otvara se novi prozor)

Levy JH, Welsby I, Goodnough LT.

Izvor‎: Transfusion 2014;54(5):1389-405.

Indeks‎: PubMed 24117955

DOI‎: 10.1111/trf.12431

https://www.ncbi.nlm.nih.gov/pubmed/24117955 (otvara se novi prozor)

Coagulopathy and placental abruption: changing management with ROTEM-guided fibrinogen concentrate therapy. (otvara se novi prozor)

McNamara H, Mallaiah S, Barclay P, Chevannes C, Bhalla A.

Izvor‎: Int J Obstet Anesth 2015;24(2):174-9.

Indeks‎: PubMed 25659517

https://www.ncbi.nlm.nih.gov/pubmed/25659517 (otvara se novi prozor)

Haemostatic monitoring during postpartum haemorrhage and implications for management. (otvara se novi prozor)

Solomon C, Collis RE, Collins PW.

Izvor‎: Br J Anaesth 2012;109(6):851-63.

Indeks‎: PubMed 23075633

DOI‎: 10.1093/bja/aes361

https://www.ncbi.nlm.nih.gov/pubmed/23075633 (otvara se novi prozor)